ACE Gene

📖 Wiki Page

gene972 wordssynced 2026-04-02

ACE Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ACE Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>ACE</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Angiotensin-Converting Enzyme</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17q23.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>1636</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000159640</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P12821</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>106180</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Metalloprotease (M2 family)</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Human</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), Cardiovascular Disease, Hypertension, SARS-CoV-2</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Captopril</td>
<td>Inhibitor</td>
</tr>
<tr>
<td class="label">Lisinopril</td>
<td>Inhibitor</td>
</tr>
<tr>
<td class="label">Enalapril</td>
<td>Inhibitor</td>
</tr>
<tr>
<td class="label">Ramipril</td>
<td>Inhibitor</td>
</tr>
<tr>
<td class="label">Perindopril</td>
<td>Inhibitor</td>
</tr>
</table>

...

ACE Gene

Introduction

Ace Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Pathway Diagram

Mermaid diagram (expand to render)

Knowledge graph relationships for ACE (311 total edges in KG)

Overview

The ACE gene encodes angiotensin-converting enzyme (ACE), a key component of the renin-angiotensin system (RAS) that regulates blood pressure, fluid balance, and electrolyte homeostasis. ACE is a zinc-dependent metalloprotease that converts angiotensin I (Ang I) to the potent vasoconstrictor angiotensin II (Ang II). Beyond its cardiovascular roles, ACE has significant implications for neurodegenerative diseases, particularly Alzheimer's disease, where ACE activity influences [Aβ](/proteins/amyloid-beta) metabolism and neuroinflammation. The ACE I/D polymorphism (insertion/deletion) is one of the most studied genetic variants in relation to AD risk and cardiovascular disease.

Molecular Function

ACE is a dipeptidyl carboxypeptidase with two homologous catalytic domains (N- and C-domains):

Angiotensin conversion: Ang I → Ang II (vasoconstrictor)
Bradykinin degradation: Inactivates bradykinin (vasodilator)
Substrate specificity: N-domain preferentially cleaves Ang I, bradykinin; C-domain processes Ang I
Zinc binding: Active site contains Zn2+ coordinated by three histidine residues
Somatic ACE: Contains two catalytic domains; germinal ACE has one domain

Key characteristics:

Two isoforms: Somatic ACE (two domains) and testicular/germinal ACE (one domain)
Membrane-bound: Type I transmembrane protein with extracellular domain
Soluble form: Can be shed from membrane
ACE2: Related enzyme that converts Ang II to Ang(1-7)

Expression Pattern

Tissue Distribution

Highest: Lung, kidney (proximal tubules)
High: Testis, heart, brain (cerebral [cortex](/brain-regions/cortex), hippocampus)
Moderate: Vascular endothelium, adrenal gland, liver
Low: Most other tissues

Brain Expression

[Neurons](/entities/neurons): Cortical neurons, hippocampal neurons
Glia: [Astrocytes](/entities/astrocytes), [microglia](/entities/microglia)
Vasculature: Cerebral blood vessels
Choroid plexus: High expression

Role in Neurodegenerative Diseases

Alzheimer's Disease

ACE plays complex roles in AD pathogenesis:

Aβ metabolism: ACE can degrade Aβ peptides, particularly Aβ1-40
Angiotensin II effects: Ang II promotes neuroinflammation and oxidative stress
Cerebral blood flow: ACE affects cerebrovascular function
Genetic association: ACE I/D polymorphism affects AD risk
Therapeutic implications: ACE inhibitors may reduce AD risk

Parkinson's Disease

Neuroinflammation: ACE modulates neuroinflammatory responses
Dopaminergic neurons: ACE affects survival of dopaminergic neurons
L-dopa response: ACE activity may affect treatment response
Gene variants: ACE polymorphisms linked to PD risk

Stroke and Vascular Dementia

Blood pressure: ACE regulates cerebral perfusion
Stroke risk: ACE inhibitors reduce stroke risk
White matter lesions: ACE affects small vessel disease

SARS-CoV-2/COVID-19

Viral entry: ACE2 is the viral receptor; ACE/ACE2 balance important
Neurological symptoms: COVID-19 can affect the brain
Research: ACE inhibitors may have protective effects

Therapeutic Implications

Current Therapeutics

Alzheimer's Disease

Observational studies: ACE inhibitor use associated with reduced AD risk
Clinical trials: Mixed results; some benefit seen
Mechanisms: Reduced Ang II, enhanced bradykinin, decreased inflammation
Combination therapy: ACEi + other approaches under investigation

Research Directions

Brain-penetrant ACE inhibitors: Develop CNS-selective compounds
ACE modulators: Selective N-domain or C-domain inhibitors
ACE2 activators: Enhance protective ACE2 signaling
Gene therapy: AAV-delivered ACE variants

Animal Models

ACE Knockout Mice

Blood pressure: Hypotension due to low Ang II
Bradykinin: Accumulation of bradykinin
Kidney: Renal developmental abnormalities
Fertility: Male infertility (germinal ACE)

Transgenic Models

Neuron-specific ACE overexpression
AD models with ACE manipulation
Cardiovascular disease models

Research Directions

Biomarkers: ACE activity as a biomarker

Personalized medicine: ACE genotyping for treatment selection

Combination therapies: ACEi with AD-directed therapies

Neuroprotection: ACE modulation for neuroprotection

Background

The study of Ace Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Allen Brain Atlas Data

Angiotensin-converting enzyme (ACE) expression in the human brain has been characterized through the Allen Brain Atlas:

Primary Expression: ACE is expressed in [endothelial cells](/cell-types/endothelial-cells) of blood vessels throughout the brain, with lower expression in neurons
Regional Distribution: Highest expression in brain regions with dense vascular networks, including the hippocampus and cerebral cortex
Cellular Localization: Primarily localized to vascular endothelial cells; expression in microglia is inducible during inflammation
Disease Relevance: ACE expression in the brain renin-angiotensin system is relevant to hypertension-related cerebrovascular damage and vascular contributions to AD

[Allen Brain Atlas Human Brain Atlas](https://human.brain-map.org/)
[Allen Brain Atlas Gene Expression](https://mouse.brain-map.org/gene/index)

External Links

[NCBI Gene: ACE](https://www.ncbi.nlm.nih.gov/gene/1636)
[UniProt: ACE](https://www.uniprot.org/uniprot/P12821)
[Human Protein Atlas: ACE](https://www.proteinatlas.org/ENSG00000159640-ACE)
[IUPHAR Database: ACE](https://www.guidetopharmacology.org/GRID/IUPHAR/ACE.jsp)
[PharmGKB: ACE](https://www.pharmgkb.org/gene/PA26239)

References

[Unknown, - Cloning of human ACE (n.d.)](https://pubmed.ncbi.nlm.nih.gov/3514149/)

[Unknown, - ACE I/D polymorphism and Alzheimer's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/10430058/)

[Unknown, - ACE and amyloid-beta metabolism (n.d.)](https://pubmed.ncbi.nlm.nih.gov/15668350/)

[Unknown, - ACE inhibitors and dementia risk (n.d.)](https://pubmed.ncbi.nlm.nih.gov/18492763/)

[Unknown, - Renin-angiotensin system in the brain (n.d.)](https://pubmed.ncbi.nlm.nih.gov/21147853/)

[Unknown, - ACE and Parkinson's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23613588/)

[Unknown, - ACE2 and COVID-19 (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25891078/)

[Unknown, - Brain ACE in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/32061054/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation](/hypothesis/h-9e9fee95) — 0.77 · Target: HCRTR1/HCRTR2
[Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulation](/hypothesis/h-fb56c8a0) — 0.69 · Target: SDC1
[Matrix Stiffness Normalization via Targeted Lysyl Oxidase Inhibition](/hypothesis/h-82922df8) — 0.69 · Target: LOX/LOXL1-4
[Astroglial Gap Junction Coordination via Connexin-43 Phosphorylation Modulation](/hypothesis/h-3a901ec3) — 0.66 · Target: GJA1
[Pericyte Contractility Reset via Selective PDGFR-β Agonism](/hypothesis/h-73e4340b) — 0.56 · Target: PDGFRB
[Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modulation](/hypothesis/h-9eae33ba) — 0.56 · Target: KCNK2
[Osmotic Gradient Restoration via Selective AQP1 Enhancement in Choroid Plexus](/hypothesis/h-0dea0ed5) — 0.51 · Target: AQP1

Related Analyses:

[Perivascular spaces and glymphatic clearance failure in AD](/analysis/SDA-2026-04-01-gap-v2-ee5a5023) 🔄
[Extracellular vesicle biomarkers for early AD detection](/analysis/SDA-2026-04-02-gap-ev-ad-biomarkers) 🔄

Pathway Diagram

The following diagram shows the key molecular relationships involving ACE Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

ACE Gene

ACE Gene

Introduction

ACE Gene

Introduction

Pathway Diagram

Overview

Molecular Function

Expression Pattern

Tissue Distribution

Brain Expression

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Stroke and Vascular Dementia

SARS-CoV-2/COVID-19

Therapeutic Implications

Current Therapeutics

Alzheimer's Disease

Research Directions

Animal Models

ACE Knockout Mice

Transgenic Models

Research Directions

Background

Allen Brain Atlas Data

Related Resources

External Links

References

Related Hypotheses

Pathway Diagram